Public recall detail

Safety information for antipsychotic drug Abilify and risk of certain impulse-control behaviours

medium
Recall Safety notice
Quick summary

Quick summary: Safety information for antipsychotic drug Abilify and risk of certain impulse-control behaviours .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Safety information for antipsychotic drug Abilify and risk of certain impulse-control behaviours .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

What you should do

  • Patients should watch for unusual impulse-related behaviours and report them to their healthcare professional. This includes an uncontrollable impulse to gamble, unusual sexual thoughts, fantasies, desires or behaviours, or any other uncontrollable behaviours that they find distressing while being treated with Abilify or Abilify Maintena.
  • Patients who have had a gambling disorder in the past may be at an increased risk of pathological gambling and should be monitored carefully by their healthcare professional.
  • Talk to your doctor if you have any questions or concerns about your treatment with Abilify or Abilify Maintena.
  • To work properly, Abilify (tablet form) should be taken every day as prescribed. Do not stop taking Abilify or change your dose without first consulting your doctor.
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...